Navigation Links
'Sharing Miracles' Features Major League Baseball Star Aaron Boone
Date:1/13/2010

WASHINGTON, Jan. 13 /PRNewswire-USNewswire/ -- The International Business Times recently reported that Major League Baseball star Aaron Boone is featured in January on 'Sharing Miracles' -- a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients.

Boone is best known for an eleventh-inning, game-winning home run in the seventh game of the 2003 American League Championship Series, which clinched the series for the New York Yankees over the Boston Red Sox.

Speaking about his memorable hit -- rated the ninth best home run in history by ESPN's Baseball Tonight -- Boone says: "Just to have had a small place in the Yankees/Red Sox rivalry is very humbling. I'm reminded of it almost every day by people around the country, no matter what side of the fence they're on. It was an epic series, an epic game between two titans, and to be a part of it was special."

However, despite his notoriety for the home run, Boone says the at-bat most meaningful to him is one that almost never happened -- his first time at home plate following open-heart surgery.

While in college, Boone was diagnosed with a bicuspid aortic valve, a congenital heart defect that required yearly check-ups, but no treatment. That all changed in March 2009, when his cardiologist advised additional tests and a consultation with a surgeon. The decision was sobering, with Boone being told he needed open-heart surgery to correct his defect.

After successfully undergoing the procedure, however, he focused on his recovery and rehabilitation and eventually realized that he was strong enough to consider a return to the sport: "I could see my body respond each day, each week, each month. Seeing myself improve really helped push me further and helped me do the necessary things to keep getting better."

That September -- just seven months after being told that he needed open-heart surgery to live - Boone accomplished the unlikely and returned to baseball, playing first base for the Houston Astros in a game against the Chicago Cubs at historic Wrigley Field.

Also featured in this month's episode is Daiichi Sankyo scientist Dr. Michael Stein, who discusses heart disease and the current research being conducted to treat and combat the disease: "This is a very exciting time in heart research and a very exciting time to be helping patients in changing the way that medical care will be delivered in cardiology in the future." In fact, more than 300 potential new medicines are currently being studied for heart disease and stroke.

Sharing Miracles airs every week on more than 300 television stations nationwide. It is sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA).

SOURCE Pharmaceutical Research and Manufacturers of America

RELATED LINKS
http://www.sharingmiracles.com/
http://www.phrma.org/

'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Sharing a hospital room increases risk of super bugs
2. Sharing Miracles Television Program to Feature Major League Baseball Star Aaron Boone
3. Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably
4. Community Health Officials Can Improve Real Time H1N1 Information Sharing with New Resources from Depiction, Inc.
5. Sharing Prescriptions Can Bring Harm, Not Healing
6. Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week
7. Sharing Miracles Television Program to Feature Baseball Manager, Cancer Survivor Joe Torre
8. GENova Biotherapeutics signs LOI with Korean university for stem cell research and patents sharing
9. Sharing Miracles Television Program to Feature Award-Winning Hollywood Star Danny Glover
10. Sharing Prescription Meds Common Among U.S. Teens
11. House Committee Approves Amendment Eliminating Cost-Sharing for Medicaid Preventive Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants ... points to eight genes that may explain why susceptibility to one of the disorders ... a study published today in the journal npj Schizophrenia. , “There is a ...
(Date:2/24/2017)... ... February 24, 2017 , ... In the Health Care IT ... top priority because it’s not if you will be attacked, but when.” However, he ... comes to digital health care. , Improvements in auditing and monitoring have taken security ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... Yisrayl makes an astounding statement when he says that the entire Bible was written ... the current times so plainly that anyone should be able to see the time ...
(Date:2/24/2017)... ... ... The Radiology Business Management Association will select the 2017 Quest ... Better Radiology Marketing Programs conference, held this year from March 5 to 7 ... given out in five categories. They are:, ,     Patient Marketing, a ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)... , Feb. 23, 2017  The particle ... million by 2021 from USD 275.9 million in ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... spending on pharmaceutical R&D, and growth in manufacturing ... the market growth for particle counters. On the ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
Breaking Medicine Technology: